Alto Pharmacy (“Alto”), the leader in America’s rapidly expanding digital pharmacy market, today announced it had raised approximately $200 million in an oversubscribed series E financing round led by returning investor Softbank Vision Fund.

After discovering that half of all prescriptions aren’t even picked up—resulting in 125,000 avoidable deaths every year—we set out to build a new kind of pharmacy that focuses on the person behind every prescription.
We’re transforming a $500 billion industry by reinventing what a pharmacy can do—from hand-delivering medications for free to offering on-call help by text or chat. Our customers are at the center of everything we do, and it shows. After delivering more than one million prescriptions, we have an NPS score of 86 and over a thousand five-star reviews on Yelp.

Alto Pharmacy Raises $200 Million Series E, Driven By Strong Growth And Expansion

Description

Company Information

Funding Insights

Alto Pharmacy Raises $200 Million Series E, Driven By Strong Growth And Expansion

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information